Loading clinical trials...
Loading clinical trials...
This study will explore the factors that influence screening behaviors of adults diagnosed with hereditary hemorrhagic telangiectasia (HHT), an inherited condition in which blood vessel defects called...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Human Genome Research Institute (NHGRI)
NCT00230620 · Telangiectasia, Hereditary Hemorrhagic
NCT00230633 · Telangiectasia, Hereditary Hemorrhagic
NCT04108052 · Telangiectasia, Hereditary Hemorrhagic, Rendu Osler Disease
NCT02484716 · Telangiectasia, Hereditary Hemorrhagic, Osler Rendu Disease
NCT02157987 · Telangiectasia, Hereditary Hemorrhagic
National Human Genome Research Institute (NHGRI), 9000 Rockville Pike
Bethesda, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions